Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
September 24, 1999
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease
E Wiedmann, B Baican, A Hertel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 1998
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors]
A N Rahn, R P Baum, I A Adamietz, et al.
Revista Espanola De Medicina Nuclear
|
April 10, 2002
[Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer]
J P Oliva, G Pimentel, M Borrón, et al.
European Journal of Pediatrics
|
May 1, 1987
131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience
D Schwabe, S Sahm, V Gerein, et al.
Revista Espanola De Medicina Nuclear
|
March 12, 1999
[Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]
J Oliva, G Pimentel, R Peralta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1996
Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT
I A Adamietz, R P Baum, F Schemman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1996
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation
M Eisenhut, W D Lehmann, W Becker, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT
R P Baum, S Adams, J Kiefer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2015
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L Bodei, M Kidd, I M Modlin, et al.
Cancer
|
February 1, 1994
Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma
R P Baum, A Niesen, A Hertel, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
September 24, 1999
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease
E Wiedmann, B Baican, A Hertel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 1998
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors]
A N Rahn, R P Baum, I A Adamietz, et al.
Revista Espanola De Medicina Nuclear
|
April 10, 2002
[Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer]
J P Oliva, G Pimentel, M Borrón, et al.
European Journal of Pediatrics
|
May 1, 1987
131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience
D Schwabe, S Sahm, V Gerein, et al.
Revista Espanola De Medicina Nuclear
|
March 12, 1999
[Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]
J Oliva, G Pimentel, R Peralta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1996
Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT
I A Adamietz, R P Baum, F Schemman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1996
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation
M Eisenhut, W D Lehmann, W Becker, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT
R P Baum, S Adams, J Kiefer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2015
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
L Bodei, M Kidd, I M Modlin, et al.
Cancer
|
February 1, 1994
Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma
R P Baum, A Niesen, A Hertel, et al.
Page
of 14